Citation

Curtis NJ, Mooney L, Hopcroft L, Michopoulos F, Whalley N, Zhong H, Murray C, Logie A, Revill M, Byth KF, Benjamin AD, Firth MA, Green S, Smith PD, Critchlow SE.: Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity. Oncotarget, Volume 8 (41), 2017

Authors

Benjamin AD, Byth KF, Critchlow SE., Curtis NJ, Firth MA, Green S, Hopcroft L, Logie A, Michopoulos F, Mooney L, Murray C, Revill M, Smith PD, Whalley N, Zhong H

Journal

Oncotarget

Year

2017

DOI

10.18632/oncotarget.18215

PubMed

29050199

Machine-readable

REST APIRDF